ABCA4 p.Arg653Ser
c.1957C>A · VCV4745910
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4968 | ambiguous |
|---|---|---|
| REVEL | 0.778 | moderately pathogenic-leaning |
| SaProt | LLR -5.62 | tolerated |
| ⇒ REVEL calls this damaging; SaProt does not; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 128 kb · p 0.24 · regional, not allelic |
| Overall | ||
| CADD | 23.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- ABCA4
- Protein
- p.Arg653Ser
- Coding
- c.1957C>A
- MANE Select
- NM_000350
- Type
- single nucleotide variant
- Location
- chr1:94060740 (GRCh38)
- Gene constraint
- LOEUF 0.786 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 75.96 · 8 PDB
- Residue 653
- a UniProt-annotated variant site (in cord3; uncertain significance); a UniProt-annotated variant site (in stgd1; uncertain significance); a UniProt-annotated variant site (found in a patient with chorioretinal atrophy; uncertain significance); a UniProt-annotated variant site (in stgd1; likely pathogenic; severely decreased, if any, n-ret-pe-stimulated atpase activity although basal activity is unchanged; decreased n-retinylidene-phosphatidylethanolamine flippase activity; severely decreased n-all-trans-retinylidenephosphatidylethanolamine binding; does not affect solubility; does not affect location in cytoplasmic vesicle); a UniProt-annotated variant site (in stgd1; likely pathogenic; severely decreased n-all-trans-retinylidenephosphatidylethanolamine binding; does not affect solubility; does not affect location in cytoplasmic vesicle; does not affect both basal and n-ret-pe-stimulated atpase activity); a binding site; an α-helix; a disulfide bond
Similar variants
- ABCA4 p.Arg653Cys Pathogenic ★★★ ⚠ same residue
- ABCA4 p.Arg653His Pathogenic ★★ ⚠ same residue
- ABCA4 p.Arg653Leu Likely pathogenic ★★ ⚠ same residue
- ABCA4 p.Arg653Gly Likely pathogenic ★ same residue
- ABCA4 p.Arg653delinsLeuSerSerTrpCys Uncertain significance ★ same residue
- ABCA4 p.Arg653fs Pathogenic same residue
- ABCA4 c.1937+1G>A Pathogenic ★★★ same type
- ABCA4 c.3328+2T>A Pathogenic ★★★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abca4-p-arg653ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown